On June 14, the 29th Annual Conference of Dermatology and Venereology of the Chinese Medical Association was held in Qingdao. The three-day academic annual meeting was hosted by the Chinese Medical Association and the Dermatology and Venereology Branch of the Chinese Medical Association, and undertaken by the Shandong Medical Association, Shandong First Medical University, and the Dermatology Hospital Affiliated to Shandong First Medical University.
As a wholly-owned subsidiary of China Resources Sanjiu Pharmaceutical Co., Ltd., CR Shunfeng has been focusing on the field of skin health, and is honored to participate in this academic annual meeting, and display its Shunfeng baby product series in the on-site brand area, and discuss the future of dermatology with dermatologists from all over the country.
Gather the professional strength of medical research to protect the skin health of infants and young children
Existing epidemiological research data show that in the past 10 years, as the "No. 1 disease" in the field of skin diseases, the prevalence of atopic dermatitis (AD) has been rising, with the prevalence of atopic dermatitis in children aged 1 to 7 years old being 12.94%, and the prevalence rate of infants under 1 year old is as high as 30.48%, and almost 3 out of every 10 babies suffer from AD.
As an infant efficacious skin care brand under China Resources Shunfeng, Shunfeng Baby relies on the deep precipitation of China Resources Shunfeng in the field of skin health care for more than 50 years, and cooperates with the Guangdong Provincial External Drug Engineering Technology Research and Development Center and the team of the Institute of Dermatology of Shanghai Jiao Tong University to tackle the skin problems caused by the damaged skin barrier of infants and young children through the "medical research and co-creation" model, and is committed to creating skin care products suitable for infants and young children, and insists on providing scientific and professional skin care solutions for infants and young children with practical actions.
Focus on the field of pediatric eczema care and empower the core technology of products
Eczema in children is a common skin problem, and its care is particularly crucial. First, the fragility of the skin barrier in children with eczema makes the skin more susceptible to external irritants, such as allergens, chemicals, and environmental factors, making care more difficult. Secondly, the itching and discomfort caused by eczema not only affect the child's daily life, but may also affect sleep and mood. In addition, the recurrence of eczema is extremely testing the patience of parents and increasing the psychological and nursing pressure of the family.
In order to solve the problem of eczema in children and relieve the worries of families. With its profound pharmaceutical R&D background and rich industry experience, CR Shunfeng continues to innovate and develop, and finally successfully breaks through the core technology of skin barrier moisturizing and repairing cream, which is applied in Shunfeng baby moisturizing cream series products. With its excellent efficacy, the technology has obtained the certificate of scientific and technological achievement issued by the Foshan Science and Technology Bureau.
The core of Shunfeng Baby's Skin Barrier Moisturizing Repair Cream lies in the innovative research and development of skin barrier moisturizing formula. Through the clever combination of key ingredients such as ceramides, free fatty acids, and phytosterols, a bionic skin barrier structure is constructed in a specific ratio, so that Shunfeng Baby Moisturizing Cream can closely adhere to human skin, increase the moisture content of the stratum corneum for a long time, and achieve excellent soothing effect.
At the same time, in order to ensure the safety of the product and reduce the risk of irritation and sensitization, on the premise of ensuring the stability of the moisturizing cream, Shunfeng Baby chooses a low-irritation emulsification formula to avoid the irritation it may bring. It also abandons traditional preservatives and adopts a milder, low-irritating antiseptic system to achieve an ideal state of no irritation, no sensitization and no toxicity, especially for children with damaged skin barriers, especially infants and young children whose immune systems have not yet fully developed, which not only brings them a significant improvement in skin condition, but also avoids secondary stimulation of the product.
Strict regulation of pharmaceutical standards, the pursuit of efficacy and safety "two-in-one"
Modern families have higher and higher selection standards for maternal and infant products, and baby care is gradually developing in the direction of fine care. When parents choose baby care products, safety has become one of the key factors in determining their purchasing decision.
As a baby skin care brand that always puts user needs first, Shunfeng Baby has been strictly standardizing production with pharmaceutical standards since its birth. The whole process implements high standards of production quality management practices, not only with a production environment higher than the standard of cosmetics, strict quality control system, and standardized production SOP for production management, but also uses GMP management concepts to implement production, and all products need to obtain a product quality inspection report before they can be released.
It is worth mentioning that in order to further improve the quality and safety of products, China Resources Shunfeng has also built a medical workshop, and opened the production process of Shunfeng Baby's products to the whole society in the way of "transparent factory", which not only reflects Shunfeng Baby's confidence in its own high standards and strict requirements in the production process, but also abides by its commitment to consumer product safety.
In order to ensure the safety of infants' skin, Shunfeng baby products have undergone strict evaluation to ensure that each product can meet the special needs of infants' skin in terms of safety and effectiveness. The product has passed multi-dimensional tests such as 3D epidermal skin model irritation test, human patch test, toxicology test, egg embryo test, risk substance assessment, etc., to ensure that the product is gentle, safe and in line with national standards.
For a long time, Shunfeng Baby, as an infant efficacious skin care brand, adheres to the R&D tenet of medical research and co-creation, continues to provide effective and safe solutions for problem skin, and will continue to provide safer and more secure, high-risk, soothing and intimate Shunfeng Baby series products for the new generation of parents in the future, providing a strong protective barrier for the healthy growth of infants and young children.